PKH Ventures IPO opens for subscription. Should you bid?

PKH Ventures has launched its initial public offering (IPO) with 1.82 crore shares of fresh equity and 73.7 lakh shares for sale by existing shareholders. The price range for the shares is set at Rs 140-148. The IPO is primarily aimed at attracting QIB investors, with 50% of the net offer reserved for them. The […]

SGX Nifty: Last working day today before delisting, new avatar as Gift Nifty from Monday

SGX Nifty, the early indicator of the Indian stock market, will shift from Singapore Exchange to NSE International Exchange in Gujarat’s Gandhinagar. SGX Nifty will be suspended and eventually delisted, while the index will be reborn as Gift Nifty on July 3. NSE IX, a subsidiary of NSE, offers USD-denominated Nifty derivatives and will have […]

Sensex, Nifty at record high. Time to be greedy or fearful ahead of Q1 test?

Foreign institutional investors (FIIs) have invested $10 billion in Indian equities in the first quarter of FY24, leading to a rally in the stock market. Analysts believe that India is a preferred destination for investors looking for alternatives to China. The participation in the rally has been broad-based, with mid and smallcaps outperforming. With reasonable […]

Stocks to buy today: Sun Pharma, L&T among top 9 trading ideas

The Indian market is expected to open higher but may consolidate at higher levels due to mixed global cues. The Sensex rose nearly 500 points and the Nifty50 closed at a fresh record high on Wednesday. India VIX increased by 1%, remaining below 11 zones which support the bulls. Options data suggests a trading range […]

Hot Stocks: Brokerage view on Mankind Pharma, Delhivery, Suzlon and ICICI Lombard

Brokerage firms have issued their recommendations on various companies. Motilal Oswal maintained a buy rating on ICICI Lombard with a target price of Rs 1550. Jefferies initiated a hold rating on Mankind Pharma with a target price of Rs 1830. Bernstein initiated an outperform rating on Delhivery with a target price of Rs 460. ICICI […]

Apple stock has another 30% upside, Citi says in new buy rating

Analysts at Citigroup believe that Apple Inc. still has the potential to rally another 30%, even after recent gains that took the company’s valuation close to $3 trillion. Atif Malik, an analyst at Citigroup, started coverage of Apple with a buy rating and a $240 price target, the highest among Wall Street analysts. Malik believes […]